Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
expressed in renal carcinomas in Tsc2 gene mutant Eker rats but is not expressed in normal kidney; may be a marker for early stage renal carcinogenesis. Additionally we are shipping and many more products for this protein.
Showing 10 out of 60 products:
Human Polyclonal FAM129A Primary Antibody for IF, WB - ABIN363060
Ji, Ding, Hawke, Xing, Jiang, Mills, Lu: AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis. in EMBO reports 2012
Data suggest that decreasing C1orf24 protein levels by restoring microRNA miR (show MLXIP Antibodies)-106b function may have therapeutic implications.
DDIT3 (show DDIT3 Antibodies), STT3A (show STT3A Antibodies), ARG2 (show ARG2 Antibodies) and FAM129A immunohistochemistry does not appear to be useful in the diagnosis of thyroid follicular neoplasias, as they do not reliably distinguish follicular thyroid carcinoma from follicular thyroid adenoma.
Gene-expression data suggest a difference in expression between STT3A (show STT3A Antibodies), Clorf24, and TFF3 (show TFF3 Antibodies) in FAs (show FAS Antibodies) versus carcinomas that may be detected from an FNA sample. Findings must be validated from preoperative FNAs in larger numbers
The expression of Niban frequently begins in the early stages of head and neck squamous carcinoma and remains upregulated throughout the carcinogenic process. Niban may be a good molecular marker of HNSCC.
Niban expression is up-regulated in various types of thyroid tumors.
expressed in renal carcinomas in Tsc2 gene mutant Eker rats but is not expressed in normal kidney; may be a marker for early stage renal carcinogenesis
cell growth-inhibiting gene 39 protein
, protein Niban